SCHEMBL9728890

SCHEMBL9728890

CCCCN(CCCC)Cc1cc(NC(=O)Nc2c(C(C)C)cccc2C(C)C)n(Cc2ccccc2)n1

nearest known ligand 0.49

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KCNJ6 P48051 2/20 0.49
KCNJ5 P48544 2/20 0.49
KCNJ3 P48549 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9729684 0.72
SCHEMBL9872794 0.71 SOAT2 (0.46) KCNJ6KCNJ5KCNJ3
SCHEMBL9728818 0.70 SMN1; SMN2 (0.49)
SCHEMBL9729291 0.69
SCHEMBL9729446 0.67 MEN1 (0.44)
SCHEMBL9873553 0.67 SMN1; SMN2 (0.47)
SCHEMBL7569944 0.67
SCHEMBL9729102 0.66
SCHEMBL9723419 0.66 SOAT2 (0.51)
SCHEMBL8984907 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5162360-A Treating hypercholesterolemia and atherosclerosis; ACAT acyl-coenzyme A:-cholesterol acyltransferase WARNER-LAMBERT COMPANY (US) 1992-11-10 US disclosed